Page last updated: 2024-09-04

docetaxel anhydrous and Peritoneal Neoplasms

docetaxel anhydrous has been researched along with Peritoneal Neoplasms in 132 studies

Research

Studies (132)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (1.52)	18.2507
2000's	45 (34.09)	29.6817
2010's	80 (60.61)	24.3611
2020's	5 (3.79)	2.80

Authors

Authors	Studies
Aghighi, M; Crossland, D; Samankan, S; Taherian, M	1
Chen, LF; Ji, ZH; Li, XB; Li, Y; Lin, YL; Ma, R; Yan, FC; Yang, ZR; Zhang, J	1
Huitema, ADR; Koemans, WJ; van Sandick, JW	1
de Jong, LAW; de Reuver, PR; van Erp, NP	1
Boerma, D; Boot, H; Grootscholten, C; Hartemink, KJ; Kodach, L; Koemans, WJ; Los, M; Sikorska, K; Snaebjornsson, P; van der Kaaij, RT; van Sandick, JW; Veenhof, AAFA; Wassenaar, ECE	1
Chang, H; Du, XM; Gao, Y; Li, Y; Li, Z; Wei, YP; Zhang, JM	1
Han, B; He, L; Li, Y; Yuan, J	1
Al-Batran, SE; Arnold, D; Bechstein, W; Berkhoff, S; Egger, M; Fischbach, W; Grimm, K; Hartmann, JT; Höffkes, HG; Hofheinz, RD; Homann, N; Illerhaus, G; Jäger, E; Koenigsmann, M; Kraus, TW; Luley, KB; Martens, UM; Mayer, F; Messmann, H; Moehler, M; Mönig, S; Pauligk, C; Post, S; Prasnikar, N; Probst, S; Ronellenfitsch, U; Schmalenberg, H; Stoehlmacher, J	1
An, Z; Chen, FF; Fang, XD; Ji, FJ; Jiang, JN; Liu, XS; Wu, YY	1
Becker, DA; Bevis, KS; Leath, CA; Smith, BQ; Walters-Haygood, CL	1
Al-Batran, SE; Behringer, D; Daum, S; Hacker, U; Ibach, S; Knödler, M; Körfer, J; Kullmann, F; Kunzmann, V; Lindhofer, H; Lordick, F; Schenk, M; Schroll, S; Stahl, M; Trojan, J	1
Inayat, F; Lodhi, HT; Ullah, W; Zafar, F	1
Antonuzzo, L; Aprile, G; Avallone, A; Bordonaro, R; Cinieri, S; Di Donato, S; Fanotto, V; Fornaro, L; Gerratana, L; Giampieri, R; Leone, F; Melisi, D; Nichetti, F; Pellegrino, A; Rimassa, L; Rosati, G; Santini, D; Scartozzi, M; Silvestris, N; Stragliotto, S; Tomasello, G; Vasile, E	1
Bouvet, M; Chawla, SP; Endo, I; Higuchi, T; Hiroshima, Y; Hoffman, RM; Kawaguchi, K; Kiyuna, T; Kumamoto, T; Li, Y; Matsuyama, R; Miyake, K; Miyake, M; Murakami, T; Nelson, SD; Oshiro, H; Razmjooei, S; Singh, SR; Wangsiricharoen, S; Zhang, Z	1
Adachi, S; Hayashida, H; Higaki, N; Kawanaka, S; Nezu, R; Oka, Y; Okada, K; Taniguchi, S; Ueshima, S; Yoshioka, S	1
Fujiwara, A; Hama, N; Hamakawa, T; Hirao, M; Kato, S; Kato, T; Maeda, S; Miyake, M; Miyamoto, A; Miyazaki, M; Nakamori, S; Nishikawa, K; Sekimoto, M; Takami, K; Uemura, M	1
Okabe, H	1
Fujimura, T; Fushida, S; Goda, F; Hirono, Y; Kaji, M; Kinoshita, J; Oyama, K; Sudo, Y; Watanabe, Y; Yagi, Y	1
Armstrong, DK; Coleman, RL; Phillips, M; Weil, SC; White, AJ	1
Apte, SM; Gonzalez-Bosquet, J; Havrilesky, LJ; Herschberger, A; Judson, PL; Lancaster, JM; Lapolla, J; Lin, HY; Secord, AA; Wenham, RM	1
Goto, S; Kamigaki, T; Saito, M; Yano, K	1
Atsumi, Y; Hasegawa, S; Imada, T; Masuda, M; Nemoto, H; Oshima, T; Rino, Y; Sato, T; Tamagawa, H; Uchiyama, M; Yoshikawa, T; Yukawa, N	1
Aydin, S; Danse, E; Machiels, JP; Rizk, R; Tombal, B	1
Canbay, E; Hirano, M; Ichinose, M; Ishibashi, H; Mizumoto, A; Sako, S; Takao, N; Yonemura, Y	1
Fujita, H; Fujita, J; Funaki, H; Kaida, D; Kinami, S; Kosaka, T; Morioka, E; Nakano, Y; Noguchi, M; Ohnishi, T; Ohno, Y; Tomita, Y; Ueda, N	1
Cho, H; Fujikawa, H; Iwasaki, K; Kasahara, A; Masuda, M; Ogata, T; Osaragi, T; Rino, Y; Shirai, J; Sujishi, K; Tsuburaya, A; Yamada, T; Yamamoto, Y; Yoneyama, K; Yoshikawa, T	1
Ebisui, C; Fukuchi, N; Kato, R; Kinuta, M; Makino, S; Murata, K; Okada, K; Okamura, S; Takeoka, T; Wada, Y; Yanagisawa, T; Yokouchi, H	1
Bell, MC; Braly, P; Childs, BH; Drake, RD; Einstein, MH; Herzog, TJ; Hines, JF; Monk, BJ; Roman, LD; Rose, PG; Secord, AA; Wenham, RM	1
Barone, M; Basilico, R; Carella, C; Colasante, A; De Tursi, M; Filippone, A; Guetti, L; Mani, A; Massari, R	1
Anderson, GL; Bonebrake, AJ; Chambers, SK; Coleman, RL; Delmore, JE; Hu, W; Markman, M; Moon, J; Sood, AK	1
Fan, R; Guo, G; Han, B; Luo, Y; Peng, X; Wang, Y; Wu, M; Zheng, Y; Zhou, L	1
Cho, H; Kim, JH; Kim, S; Kim, SW; Kim, YT; Lee, M; Nam, EJ	1
DePoint Christensen, R; Havsteen, H; Herrstedt, J; Kristensen, G; Lund, B; Maenpaa, J; Mirza, MR; Wang, Y	1
Ebisui, C; Fukuchi, N; Kinuta, M; Murata, K; Nushijima, Y; Okada, K; Okamura, S; Yanagisawa, T; Yokouchi, H	1
Canbay, E; Hirano, M; Ichinose, M; Ikeda, S; Ishibashi, H; Li, Y; Liu, Y; Mizumoto, A; Noguchi, A; Sai, Y; Sako, S; Takao, N; Takeshita, K; Yonemura, Y	1
Aldemir, MN; Bilen, N; Bilici, M; Cayir, K; Makas, I; Simsek, M; Tekin, SB; Turkeli, M; Yildirim, N	1
Doki, Y; Hamakawa, T; Kurokawa, Y; Miyata, H; Miyazaki, Y; Mori, M; Nakajima, K; Takahashi, T; Takiguchi, S; Yamasaki, M	1
Hotopp, T; Müller, H; Tofeili, A; Wutke, K	1
Hoshi, K; Hosoda, K; Katada, N; Kikuchi, S; Mieno, H; Moriya, H; Ushiku, H; Watanabe, M; Yamashita, K	1
Fan, R; Gao, X; Guo, G; Li, X; Mei, L; Tong, A; You, C; Zhang, X; Zhou, L	1
Hiratsuka, M; Ishibashi, Y; Ito, Y; Morita, A; Omori, K; Saito, H; Suda, H; Suematsu, Y; Takahashi, M; Wakabayashi, K	1
Ito, M; Kitano, M; Kunishige, T; Matsumoto, S; Migita, K; Nakade, H; Nakajima, Y; Nakatani, M; Tanaka, T; Wakatsuki, K	1
Cooray, P; Ferraro, DA; Ganju, V; Gebski, V; Hall, M; Pavlakis, N; Price, TJ; Shannon, JA; Sjoquist, KM; Strickland, A; Tebbutt, NC; Underhill, C; Varma, SC; Veillard, AS; Wong, N; Young, R	1
Ji, ZH; Li, Y; Peng, KW; Sun, JH; Wu, HT; Yonemura, Y; Zhang, Q	1
Batlett, D; Canbay, E; Coccolini, F; Deraco, M; Elias, D; Glehen, O; Gonzaletz-Moreno, S; Ishibashi, H; Li, Y; Mahtem, H; Mizumoto, A; Moran, B; Morris, D; Piso, P; Sugarbaker, PH; Verwaal, V; Yonemura, Y	1
Chaudhry, NA; Coman, R; Zahid, K; Zhang, Q	1
Huang, CQ; Ji, ZH; Li, Y; Peng, KW; Sun, JH; Wu, HT; Yang, XJ; Zhang, Q	2
Chi, DS; Gardner, GJ; Long Roche, K; Mueller, JJ; O'Cearbhaill, RE; Schlappe, BA; Sonoda, Y; Zivanovic, O	1
Afors, K; Akladios, C; Baldauf, JJ; Hummel, M; Kurtz, JE; Lecointre, L; Marchal, F; Mathelin, C; Petit, T; Rebstock, LE; Schrot-Sanyan, S	1
Concin, N; Koelbl, H; Nehoda, R; Polterauer, S; Reinthaller, A; Seebacher, V	1
Bamias, A; Briasoulis, E; Economopoulos, T; Fountzilas, G; Kalofonos, HP; Karina, M; Koutras, A; Pavlidis, N; Pentheroudakis, G; Samantas, E; Samelis, G; Xiros, N	1
Baldridge, LA; Breen, T; Emerson, RE; Johnson, CS; Matei, D; McClean, J; Menning, N; Schilder, J; Stephens, D; Sutton, G; Whalen, C	1
Doki, Y; Fujiwara, Y; Miyata, H; Nakajima, K; Nishida, T; Takiguchi, S; Yamazaki, M	1
Ito, C; Kamijo, Y; Miyamoto, K; Nomura, M; Sai, Y	1
Endou, Y; Hirano, M; Ichinose, M; Ikeda, M; Ikeda, S; Kimura, H; Masuda, S; Matsuda, T; Matsuki, N; Miura, M; Mizumoto, A; Mizuno, M; Nakajima, G; Sasaki, T; Shinbo, M; Takao, N; Yonemura, J; Yonemura, Y; Yuuba, T	1
Futagawa, S; Kitajima, M; Konishi, N; Marusasa, T; Nishimura, K; Ochiai, T; Satoh, G; Watanabe, T	1
Bender, GP; Masellis, AM; Sielaff, TD	1
Chang, HM; Kang, YK; Kim, BS; Kim, TW; Lee, JL; Oh, ST; Ryu, MH; Sym, SJ; Yook, JH	1
Groe, R; Grothey, A; Kantelhardt, EJ; Kegel, T; Koelbl, H; Mueller, LP; Schmoll, HJ; Seliger, G; Strauss, HG; Thomssen, C	1
Hasegawa, H; Kijima, T; Kitahara, M; Kubo, H; Miyahara, M; Tada, K	1
Bazin, IS; Fedyanin, MY; Garin, AM; Kanagavel, D; Narimanov, MN; Pokataev, IA; Tjulandin, SA; Tryakin, AA; Yakovleva, ES	1
Almhanna, K; Bekai-Saab, T; Dawson, S; El-Rayes, BF; Hammad, N; Heilbrun, LK; Patel, B; Philip, PA; Shields, AF; Smith, D; Urba, S; Vaishampayan, U; Zalupski, M	1
Doki, Y; Fujiwara, Y; Miyata, H; Moon, JH; Mori, M; Nakajima, K; Nishida, T; Takiguchi, S; Yamamoto, K; Yamasaki, M	1
Kang, WK; Kim, ST; Lee, J; Lim, HY; Park, JO; Park, JY; Park, SH; Park, YS	1
Boku, N; Hironaka, S; Kojima, T; Machida, N; Muro, K; Shitara, K; Taku, K; Ueda, S; Yamazaki, K; Yokota, T	1
Hachisuka, T; Hattori, K; Kinoshita, T; Miyauchi, M; Mori, T; Shikano, T; Shinohara, M; Yamamoto, T	1
Ahn, EH; Eno, ML; Im, DD; Matsuo, K; Rosenshein, NB; Shahzad, MM; Sood, AK	1
Bonebrake, AJ; De Geest, K; Edwards, R; Hanjani, P; Monk, BJ; Rotmensch, J; Sill, MW; Walker, JL	1
Chun, CL; Dormady, S; Eisenstat, S; Lombard, C; Triadafilopoulos, G	1
Goff, B; Holmberg, LA; Veljovich, D	1
Arimoto, T; Kawana, K; Nakagawa, S; Oda, K; Taketani, Y; Yasugi, T	1
Bridges, AS; Combest, AJ; DeLoia, JA; Edwards, RP; Kelley, JL; Krivak, TC; Walko, CM; Yu, AY; Zamboni, BA; Zamboni, WC	1
Doki, Y; Fujiwara, Y; Kurokawa, Y; Miyata, H; Mori, M; Nakajima, K; Okada, K; Takiguchi, S; Yamasaki, M	1
Markman, M	1
Dohi, S; Inoue, M; Kyo, S; Ohno, S; Ohno, Y; Soma, G; Sugiyama, H; Takakura, M	1
Doki, Y; Fujiwara, Y; Kurokawa, Y; Miyata, H; Mori, M; Nakajima, K; Takiguchi, S; Yamasaki, M	1
Havrilesky, LJ; Higgins, RV; Holloway, RW; Kohler, MF; Lewandowski, GS; Nycum, LR; Pokrzywinski, R; Puls, LE; Revicki, DA; Secord, AA	1
Coleman, RL; Duska, LR; Garcia, ME; Heymach, JV; Iyer, RB; Jackson, EF; Jaffe, R; Kamat, AA; Kundra, V; Miller, DL; Modesitt, SC; Ng, CS; Ramirez, PT; Schmeler, KM; Sood, AK	1
Ota, T; Takeshima, N; Takizawa, K	1
Doki, Y; Fujiwara, Y; Kurokawa, Y; Miyata, H; Mori, M; Nakajima, K; Okada, K; Takahashi, T; Takiguchi, S; Yamasaki, M	1
Hashizume, E; Narita, T; Suzuki, A; Yajima, M	1
de Graaf, H; de Munck, L; Erdkamp, FLG; Hoekman, K; Hollema, H; Lalisang, RI; Polee, M; Reyners, AKL; Schaapveld, M; Smit, WM; van Vugt, MATM; Willemse, PHB; Wymenga, ANM	1
Enomoto, K; Ito, M; Matsumoto, S; Migita, K; Nakajima, Y; Takayama, T; Tanaka, T; Wakatsuki, K	1
Asukai, K; Hasegawa, I; Horiguchi, N; Koguchi, H; Matsunaga, S; Miura, A; Ohno, T; Sakakibara, K; Shimizu, S; Togawa, S	1
Aoki, Y; Higashiguchi, T; Iwakura, S; Kunimoto, H; Nakase, T; Shimada, K; Shimamoto, T	1
Armstrong, DK; DiSilvestro, PA; Fracasso, PM; Gould, N; Mannel, RS; Sill, MW; Thaker, PH; Waggoner, SE; Walker, JL; Yamada, SD	1
Chen, Y; Cui, Y; Feng, Y; Li, Q; Liu, T; Wang, Y; Yu, Y	1
Guven, M; Inal, A; Işikdogan, A; Kaplan, MA; Kuçukoner, M; Nas, N; Urakci, Z; Yunce, M	1
Bae, WK; Cho, CS; Cho, SH; Chung, IJ; Hwang, JE; Kim, DE; Ko, HM; Lee, JH; Park, IK; Park, MS; Shim, HJ	1
Cinar, V; Erdik, B; Oyan, B; Ozturk, MA; Ozveren, O	1
Fujii, M; Funada, T; Jinno, D; Kaiga, T; Kanamori, N; Kochi, M; Mihara, Y; Shimizu, H; Takayama, T; Tamegai, H	1
Fujimura, T; Fushida, S; Kinami, S; Miwa, K; Miyamoto, K; Nao, F; Ninomiya, I; Nishimura, G; Ohta, T; Yokogawa, K	1
Beijnen, JH; de Bree, E; Georgoulias, V; Michalakis, J; Romanos, J; Rosing, H; Tsiftsis, DD	1
Ball, HG; Blessing, JA; DeGeest, K; Hoffman, J; Moore, DH; Rose, PG; Warshal, D	1
Baba, E; Katano, M; Matsunaga, H; Morisaki, T; Nakahara, C; Nakamura, K; Noshiro, H; Tanaka, M; Wada, M; Yamanaka, N	1
Belinson, J; Kulp, B; Markman, M; Peterson, G; Webster, K; Zanotti, K	2
Chow, W; Chu, D; Doroshow, JH; Frankel, P; Leong, L; Lim, D; Lin, P; Margolin, K; Morgan, RJ; Paz, B; Schwarz, R; Shibata, S; Somlo, G; Stalter, S; Synold, T; Twardowski, P; Yen, Y	1
Bando, E; Endou, Y; Kawamura, T; Kimura, M; Kuno, K; Miyamoto, K; Sasaki, T; Shimada, T; Sugarbaker, PH; Yonemura, Y	1
Atkinson, R; Coleman, R; Gabra, H; Gordon, A; Hay, A; Jayson, GC; Kaye, SB; Parkin, D; Paul, J; Vasey, PA	1
Fujiki, H; Kadotani, Y; Kumano, T; Mitsuo, M; Morita, S; Oda, T; Sonoyama, Y; Yasuoka, R	1
Atkinson, T; Berkenblit, A; Cannistra, SA; Krasner, CN; Matulonis, UA; Mezzetti, L; Penson, RT; Roche, M; Seiden, MV	1
Endo, Y; Miyamoto, K; Nomura, M; Sasaki, T; Shimada, T; Yokogawa, K; Yonemura, Y	1
Kawasaki, H; Kobori, H; Maruyama, M; Sasaki, M; Seino, K; Shibata, S; Sugiyama, Y; Yamada, K	1
Asai, S; Dokoh, J; Ishikawa, M; Komiyama, S; Mikami, M; Tsuji, H	1
Hamai, Y; Hihara, J; Tanabe, K; Toge, T; Ukon, K; Yoshida, K	1
Hirakawa, K; Ishikawa, T; Komoto, M; Nakata, B; Nomura, S; Ohira, M; Sawada, T; Takashima, T	1
Bando, E; Endou, Y; Kawamura, T; Miyamoto, K; Sasaki, T; Shimada, T; Tanaka, M; Tochiori, S; Yonemura, Y	1
Chan, S; Clamp, AR; Cruickshank, D; Hindley, A; Jayson, GC; Ledermann, J; Mäenpää, J; Sorbe, B; Vasey, P; Welch, R; Wilkinson, PM	1
Atkinson, R; Coleman, R; Kaye, S; Lewsley, L; Osborne, R; Parkin, D; Paul, J; Reed, NS; Rustin, GJ; Symonds, R; Vasey, PA	1
Kimura, H; Koyama, F	1
Beijnen, JH; de Bree, E; Georgoulias, V; Michalakis, J; Relakis, K; Romanos, J; Rosing, H; Theodoropoulos, PA; Tsiftsis, DD	1
Bandou, E; Endou, Y; Sasaki, T; Sawa, T; Sugarbaker, PH; Yonemura, Y; Yoshimitsu, Y	1
Bae, JM; Choi, IJ; Chun, JH; Kim, CG; Kim, HK; Kim, YW; Lee, JH; Lee, JS; Park, SR; Ryu, KW; Yu, MS	1
Baumgart, A; Henze, A; Karbe, I; Koelbl, H; Strauss, HG; Teichmann, A; Thomssen, C	1
Ishii, E; Kondo, M; Munakata, M; Sakata, Y; Shitara, K; Wada, R	1
Miyade, Y; Ninomiya, M; Ohtani, S; Shimizu, Y; Sugiyama, S	1
Bailey, HH; Connor, JP; Fine, J; Harris, LS; Hartenbach, EM; Kushner, DM; Sanchez, F; Schink, JC; Stewart, SL; Volk, M	1
Aoki, T; Hibi, Y; Hoshino, S; Ito, K; Katayanagi, S; Suda, T; Sudo, H; Takagi, Y; Tsuchida, A	1
Ember, A; Esik, O; Horváth, OP; Kalmár, K; Papp, A; Yousuf, AF	1
Astone, A; Barone, C; Basso, M; Cassano, A; D'Argento, E; Pozzo, C; Quirino, M; Schinzari, G; Trigila, N	1
Bilancia, D; Dinota, A; Germano, D; Manzione, L; Reggiardo, G; Romano, R; Rosati, G	1
Assmann, M; Deist, T; Fahlke, J; Hribaschek, K; Keilholz, U; Kettner, E; Lippert, H; Quietzsch, D; Ridwelski, K; Schmidt, C; Stuebs, P	1
Doki, Y; Fujiwara, Y; Miyata, H; Monden, M; Nishida, T; Takiguchi, S; Yamazaki, M	1
Fujimura, T; Fukushima, N; Fushida, S; Goda, F; Hirono, Y; Imano, M; Kaji, M; Kurita, A; Kurita, N; Nashimoto, A; Ohta, T; Tanemura, H; Tsujitani, S; Watanabe, Y; Yamaguchi, K	1
Fujimura, T; Funaki, H; Fushida, S; Kayahara, M; Kinami, S; Kinoshita, J; Ninomiya, I; Nishimura, G; Ohta, T; Yagi, Y	1
Carty, K; Gabra, H; Gore, M; Guastalla, JP; Kaye, S; Lauraine, EP; Paul, J; Rustin, G; Vasey, PA; Wilson, R	1
D'Incalci, M; Giavazzi, R; Lucchini, V; Nicoletti, MI	1
Schrijvers, D; van Dam, P; van Oosterom, A	1
Atkinson, EN; Guedes, Ed; Kavanagh, JJ; Kudelka, AP; Nelson-Taylor, T; Rogers, R; Sittisomwong, T; Steger, M; Verschraegen, CF; Vincent, M	1
Belinson, J; Kennedy, A; Kulp, B; Markman, M; Peterson, G; Webster, K	1

Reviews

7 review(s) available for docetaxel anhydrous and Peritoneal Neoplasms

Article	Year
Long-term survival of high-grade primary peritoneal papillary serous adenocarcinoma: a case report and literature review. World journal of surgical oncology, 2017, Apr-11, Volume: 15, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Cancer, Regional Perfusion; Combined Modality Therapy; Cystadenocarcinoma, Papillary; Cystadenocarcinoma, Serous; Cytoreduction Surgical Procedures; Docetaxel; Female; Humans; Hyperthermia, Induced; Middle Aged; Neoplasm Grading; Peritoneal Neoplasms; Prognosis; Survival Rate; Taxoids; Thoracic Surgery, Video-Assisted	2017
[Curative resection of a case of advanced gastric cancer with peritoneal dissemination responding well to combination chemotherapy of docetaxel,cisplatin and S-1]. Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:9 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Docetaxel; Drug Combinations; Gastrectomy; Humans; Male; Oxonic Acid; Peritoneal Neoplasms; Stomach Neoplasms; Taxoids; Tegafur	2013
[A case of jejnal cancer who was controlled peritoneal metastasis, successfully by combination therapy with docetaxel and S-1]. Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:12 Topics: Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Humans; Jejunal Neoplasms; Male; Middle Aged; Oxonic Acid; Peritoneal Neoplasms; Radiography; Taxoids; Tegafur; Treatment Outcome	2013
[Long-Term Disease-Free Survival through Postoperative Chemotherapy in a Case of Gastric Cancer with Peritoneal Dissemination]. Gan to kagaku ryoho. Cancer & chemotherapy, 2015, Volume: 42, Issue:12 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Docetaxel; Drug Combinations; Gastrectomy; Humans; Lymph Node Excision; Male; Oxonic Acid; Peritoneal Neoplasms; Stomach Neoplasms; Taxoids; Tegafur; Treatment Outcome	2015
A comprehensive treatment for peritoneal metastases from gastric cancer with curative intent. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2016, Volume: 42, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytoreduction Surgical Procedures; Docetaxel; Drug Combinations; Humans; Hyperthermia, Induced; Infusions, Parenteral; Multivariate Analysis; Neoadjuvant Therapy; Oxonic Acid; Peritoneal Neoplasms; Peritoneum; Stomach Neoplasms; Taxoids; Tegafur	2016
Takotsubo syndrome: an underdiagnosed complication of 5-fluorouracil mimicking acute myocardial infarction. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2013, Volume: 24, Issue:1 Topics: Amiodarone; Anti-Arrhythmia Agents; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Combined Modality Therapy; Coronary Angiography; Diagnostic Errors; Docetaxel; Electric Countershock; Fatal Outcome; Fluorouracil; Gastrectomy; Humans; Irinotecan; Leucovorin; Lymphatic Metastasis; Male; Middle Aged; Myocardial Infarction; Peritoneal Neoplasms; Peritonitis; Stomach Neoplasms; Takotsubo Cardiomyopathy; Taxoids; Ventricular Fibrillation	2013
Intraperitoneal chemotherapy with taxanes for ovarian cancer with peritoneal dissemination. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2006, Volume: 32, Issue:6 Topics: Antineoplastic Agents, Phytogenic; Docetaxel; Female; Humans; Hyperthermia, Induced; Infusions, Parenteral; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Prognosis; Taxoids	2006

Trials

46 trial(s) available for docetaxel anhydrous and Peritoneal Neoplasms

Article	Year
Tumor characteristics and clinical outcome of peritoneal metastasis of gastric origin treated with a hyperthermic intraperitoneal chemotherapy procedure in the PERISCOPE I trial. Journal of surgical oncology, 2021, Volume: 123, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytoreduction Surgical Procedures; Docetaxel; Female; Follow-Up Studies; Humans; Hyperthermia, Induced; Hyperthermic Intraperitoneal Chemotherapy; Male; Middle Aged; Oxaliplatin; Peritoneal Neoplasms; Prognosis; Stomach Neoplasms; Survival Rate	2021
Effect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Cancer: The AIO-FLOT3 Trial. JAMA oncology, 2017, Sep-01, Volume: 3, Issue:9 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Docetaxel; Esophagogastric Junction; Fluorouracil; Gastrectomy; Humans; Leucovorin; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Metastasectomy; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Peritoneal Neoplasms; Prospective Studies; Stomach Neoplasms; Survival Rate; Taxoids; Young Adult	2017
Utilization of an Alternative Docetaxel-based Intraperitoneal Chemotherapy Regimen in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma: A Continued Need for Ovarian Cancer Patients. American journal of clinical oncology, 2019, Volume: 42, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Docetaxel; Fallopian Tube Neoplasms; Female; Humans; Middle Aged; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Treatment Outcome	2019
Randomised phase II trial to investigate catumaxomab (anti-EpCAM × anti-CD3) for treatment of peritoneal carcinomatosis in patients with gastric cancer. British journal of cancer, 2018, Volume: 119, Issue:3 Topics: Adult; Aged; Antibodies, Bispecific; Antineoplastic Combined Chemotherapy Protocols; CD3 Complex; Docetaxel; Epithelial Cell Adhesion Molecule; Female; Fluorouracil; Gastrectomy; Humans; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Oxaliplatin; Peritoneal Neoplasms; Stomach Neoplasms	2018
Phase I/II study of intraperitoneal docetaxel plus S-1 for the gastric cancer patients with peritoneal carcinomatosis. Cancer chemotherapy and pharmacology, 2013, Volume: 71, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Oxonic Acid; Peritoneal Neoplasms; Stomach Neoplasms; Survival Rate; Taxoids; Tegafur; Treatment Outcome	2013
Farletuzumab (a monoclonal antibody against folate receptor alpha) in relapsed platinum-sensitive ovarian cancer. Gynecologic oncology, 2013, Volume: 129, Issue:3 Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Ovarian Epithelial; Disease-Free Survival; Docetaxel; Drug Hypersensitivity; Fallopian Tube Neoplasms; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Taxoids	2013
A phase II trial of docetaxel and bevacizumab in recurrent ovarian cancer within 12 months of prior platinum-based chemotherapy. Gynecologic oncology, 2013, Volume: 130, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carcinoma, Ovarian Epithelial; Disease-Free Survival; Docetaxel; Drug Resistance, Neoplasm; Drug Synergism; Fallopian Tube Neoplasms; Female; Humans; Infusions, Intravenous; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Organoplatinum Compounds; Ovarian Neoplasms; Peritoneal Neoplasms; Taxoids	2013
A phase II trial of oxaliplatin, docetaxel, and bevacizumab as first-line therapy of advanced cancer of the ovary, peritoneum, and fallopian tube. Gynecologic oncology, 2014, Volume: 132, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carcinoma, Ovarian Epithelial; Disease-Free Survival; Docetaxel; Fallopian Tube Neoplasms; Female; Humans; Middle Aged; Neoplasm Metastasis; Neoplasms, Glandular and Epithelial; Organoplatinum Compounds; Ovarian Neoplasms; Oxaliplatin; Peritoneal Neoplasms; Taxoids	2014
Randomised phase II study of docetaxel plus vandetanib versus docetaxel followed by vandetanib in patients with persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: SWOG S0904. European journal of cancer (Oxford, England : 1990), 2014, Volume: 50, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Ovarian Epithelial; Disease-Free Survival; Docetaxel; Fallopian Tube Neoplasms; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Peritoneal Neoplasms; Piperidines; Quinazolines; Taxoids; Treatment Outcome	2014
A multicenter, non-randomized, phase II study of docetaxel and carboplatin administered every 3 weeks as second line chemotherapy in patients with first relapse of platinum sensitive epithelial ovarian, peritoneal or fallopian tube cancer. BMC cancer, 2014, Dec-11, Volume: 14 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Carcinoma, Ovarian Epithelial; Chemotherapy-Induced Febrile Neutropenia; Disease Progression; Disease-Free Survival; Docetaxel; Drug Screening Assays, Antitumor; Fallopian Tube Neoplasms; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Peritoneal Neoplasms; Prospective Studies; Somatosensory Disorders; Taxoids; Treatment Outcome; Young Adult	2014
Panitumumab added to docetaxel, cisplatin and fluoropyrimidine in oesophagogastric cancer: ATTAX3 phase II trial. British journal of cancer, 2016, Mar-01, Volume: 114, Issue:5 Topics: Adenocarcinoma; Adult; Aged; Anorexia; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma, Squamous Cell; Cisplatin; Diarrhea; Disease-Free Survival; Docetaxel; Esophageal Neoplasms; Esophagogastric Junction; Fatigue; Female; Fluorouracil; Humans; Infections; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Nausea; Panitumumab; Peritoneal Neoplasms; Stomach Neoplasms; Taxoids; Treatment Outcome; Vomiting	2016
Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel improves survival for patients with peritoneal carcinomatosis from abdominal and pelvic malignancies. World journal of surgical oncology, 2016, Sep-15, Volume: 14, Issue:1 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemotherapy, Adjuvant; Chemotherapy, Cancer, Regional Perfusion; Cyclobutanes; Cytoreduction Surgical Procedures; Docetaxel; Drug Synergism; Feasibility Studies; Female; Gastrointestinal Neoplasms; Genital Neoplasms, Female; Humans; Hyperthermia, Induced; Male; Middle Aged; Organoplatinum Compounds; Peritoneal Neoplasms; Survival Rate; Taxoids; Treatment Outcome	2016
Docetaxel and carboplatin combination chemotherapy as outpatient palliative therapy in carcinoma of unknown primary: a multicentre Hellenic Cooperative Oncology Group phase II study. Acta oncologica (Stockholm, Sweden), 2008, Volume: 47, Issue:6 Topics: Adenocarcinoma; Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Carcinoma; Disease Progression; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Female; Greece; Humans; Infusions, Intravenous; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Outpatients; Palliative Care; Peritoneal Neoplasms; Predictive Value of Tests; Prognosis; Risk Factors; Taxoids; Treatment Outcome	2008
Imatinib mesylate in combination with docetaxel for the treatment of patients with advanced, platinum-resistant ovarian cancer and primary peritoneal carcinomatosis : a Hoosier Oncology Group trial. Cancer, 2008, Aug-15, Volume: 113, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Docetaxel; Drug Delivery Systems; Drug Resistance, Neoplasm; Female; Humans; Imatinib Mesylate; Middle Aged; Oncogene Protein v-akt; Organoplatinum Compounds; Ovarian Neoplasms; Peritoneal Neoplasms; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Recurrence; Survival Analysis; Taxoids; Treatment Outcome	2008
[Clinical trials of neo-adjuvant chemotherapy for advanced gastric cancer with peritoneal dissemination]. Gan to kagaku ryoho. Cancer & chemotherapy, 2008, Volume: 35, Issue:12 Topics: Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Oxonic Acid; Peritoneal Neoplasms; Stomach Neoplasms; Survival Rate; Taxoids; Tegafur	2008
Neoadjuvant docetaxel, capecitabine and cisplatin (DXP) in patients with unresectable locally advanced or metastatic gastric cancer. Annals of surgical oncology, 2010, Volume: 17, Issue:4 Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Deoxycytidine; Docetaxel; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Peritoneal Neoplasms; Stomach Neoplasms; Survival Rate; Taxoids; Tomography, X-Ray Computed; Treatment Outcome; Young Adult	2010
Phase 2 trial of docetaxel, gemcitabine, and oxaliplatin combination chemotherapy in platinum- and paclitaxel-pretreated epithelial ovarian cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2009, Volume: 19, Issue:8 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Docetaxel; Fallopian Tube Neoplasms; Female; Gemcitabine; Humans; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Organoplatinum Compounds; Ovarian Neoplasms; Oxaliplatin; Paclitaxel; Peritoneal Neoplasms; Prognosis; Prospective Studies; Risk Factors; Taxoids; Treatment Outcome; Young Adult	2009
A prognostic model in patients treated for metastatic gastric cancer with second-line chemotherapy. Annals of oncology : official journal of the European Society for Medical Oncology, 2010, Volume: 21, Issue:9 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Cisplatin; Docetaxel; Etoposide; Female; Fluorouracil; Follow-Up Studies; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Neoplasm Staging; Ovarian Neoplasms; Peritoneal Neoplasms; Prognosis; Retrospective Studies; Stomach Neoplasms; Survival Rate; Taxoids	2010
A phase II study of bevacizumab, oxaliplatin, and docetaxel in locally advanced and metastatic gastric and gastroesophageal junction cancers. Annals of oncology : official journal of the European Society for Medical Oncology, 2010, Volume: 21, Issue:10 Topics: Adenocarcinoma; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Bone Neoplasms; Docetaxel; Esophagogastric Junction; Female; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Peritoneal Neoplasms; Stomach Neoplasms; Survival Rate; Taxoids; Treatment Outcome	2010
Feasibility study of S-1 and intraperitoneal docetaxel combination chemotherapy for gastric cancer with peritoneal dissemination. Anticancer research, 2010, Volume: 30, Issue:4 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Dose-Response Relationship, Drug; Drug Combinations; Feasibility Studies; Female; Humans; Infusions, Parenteral; Male; Middle Aged; Oxonic Acid; Peritoneal Neoplasms; Remission Induction; Stomach Neoplasms; Taxoids; Tegafur	2010
Phase I study of docetaxel, cisplatin and S-1 in patients with advanced gastric cancer. Japanese journal of clinical oncology, 2010, Volume: 40, Issue:11 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Combinations; Female; Humans; Japan; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Maximum Tolerated Dose; Middle Aged; Oxonic Acid; Peritoneal Neoplasms; Stomach Neoplasms; Survival Rate; Taxoids; Tegafur; Treatment Outcome	2010
Docetaxel plus trabectedin appears active in recurrent or persistent ovarian and primary peritoneal cancer after up to three prior regimens: a phase II study of the Gynecologic Oncology Group. Gynecologic oncology, 2011, Volume: 120, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Dioxoles; Docetaxel; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Peritoneal Neoplasms; Taxoids; Tetrahydroisoquinolines; Trabectedin	2011
Unexpected gastrointestinal toxicity from Docetaxel/Carboplatin/Erlotinib followed by maintenance Erlotinib treatment for newly diagnosed stage III/IV ovarian cancer, primary peritoneal, or fallopian tube cancer. Gynecologic oncology, 2011, May-01, Volume: 121, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Docetaxel; Dose-Response Relationship, Drug; Erlotinib Hydrochloride; Fallopian Tube Neoplasms; Female; Humans; Neoplasm Staging; Ovarian Neoplasms; Peritoneal Neoplasms; Quinazolines; Taxoids	2011
Docetaxel plus trabectedin appears active in recurrent or persistent ovarian and primary peritoneal cancer after up to three prior regimes: a phase II study of the Gynecologic Oncology Group. Gynecologic oncology, 2011, Volume: 122, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Dioxoles; Docetaxel; Female; Humans; Neoplasm Recurrence, Local; Ovarian Neoplasms; Peritoneal Neoplasms; Taxoids; Tetrahydroisoquinolines; Trabectedin	2011
Health-related quality of life outcomes of docetaxel/carboplatin combination therapy vs. sequential therapy with docetaxel then carboplatin in patients with relapsed, platinum-sensitive ovarian cancer: results from a randomized clinical trial. Gynecologic oncology, 2011, Volume: 123, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Fallopian Tube Neoplasms; Female; Humans; Middle Aged; Ovarian Neoplasms; Peritoneal Neoplasms; Prospective Studies; Quality of Life; Recurrence; Severity of Illness Index; Taxoids	2011
Phase 1-2 study of docetaxel plus aflibercept in patients with recurrent ovarian, primary peritoneal, or fallopian tube cancer. The Lancet. Oncology, 2011, Volume: 12, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Fallopian Tube Neoplasms; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Peritoneal Neoplasms; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Taxoids; Time Factors; Treatment Outcome; United States	2011
A randomized phase II study investigating the addition of the specific COX-2 inhibitor celecoxib to docetaxel plus carboplatin as first-line chemotherapy for stage IC to IV epithelial ovarian cancer, Fallopian tube or primary peritoneal carcinomas: the Do Annals of oncology : official journal of the European Society for Medical Oncology, 2012, Volume: 23, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Ovarian Epithelial; Celecoxib; Cyclooxygenase 2 Inhibitors; Disease-Free Survival; Docetaxel; Fallopian Tube Neoplasms; Female; Humans; Middle Aged; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Peritoneal Neoplasms; Pyrazoles; Sulfonamides; Taxoids	2012
A phase I study with an expanded cohort to assess feasibility of intravenous docetaxel, intraperitoneal carboplatin and intraperitoneal paclitaxel in patients with previously untreated ovarian, fallopian tube or primary peritoneal carcinoma: a Gynecologic Gynecologic oncology, 2012, Volume: 127, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cohort Studies; Docetaxel; Fallopian Tube Neoplasms; Female; Humans; Infusions, Intravenous; Injections, Intraperitoneal; Middle Aged; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Taxoids	2012
Combination of low-dose docetaxel and standard-dose S-1 for the treatment of advanced gastric cancer: efficacy, toxicity, and potential predictive factor. Cancer chemotherapy and pharmacology, 2013, Volume: 71, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dihydrouracil Dehydrogenase (NADP); Docetaxel; Dose-Response Relationship, Drug; Drug Combinations; Enzyme-Linked Immunosorbent Assay; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Oxonic Acid; Peritoneal Neoplasms; Stomach Neoplasms; Survival Rate; Taxoids; Tegafur; Treatment Outcome	2013
A phase II study of docetaxel in paclitaxel-resistant ovarian and peritoneal carcinoma: a Gynecologic Oncology Group study. Gynecologic oncology, 2003, Volume: 88, Issue:2 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Docetaxel; Drug Resistance, Neoplasm; Female; Humans; Middle Aged; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Taxoids	2003
Phase I trial of intraperitoneal docetaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavity: dose-limiting toxicity and pharmacokinetics. Clinical cancer research : an official journal of the American Association for Cancer Research, 2003, Dec-01, Volume: 9, Issue:16 Pt 1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents, Phytogenic; Docetaxel; Female; Gastrointestinal Neoplasms; Humans; Infusions, Parenteral; Male; Maximum Tolerated Dose; Middle Aged; Ovarian Neoplasms; Peritoneal Neoplasms; Stomach Neoplasms; Taxoids; Treatment Outcome	2003
Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma. Journal of the National Cancer Institute, 2004, Nov-17, Volume: 96, Issue:22 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Confidence Intervals; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Female; Humans; Middle Aged; Neutropenia; Odds Ratio; Ovarian Neoplasms; Paclitaxel; Peripheral Nervous System Diseases; Peritoneal Neoplasms; Proportional Hazards Models; Quality of Life; Survival Analysis; Taxoids; Treatment Outcome	2004
A phase II trial of weekly docetaxel in patients with platinum-resistant epithelial ovarian, primary peritoneal serous cancer, or fallopian tube cancer. Gynecologic oncology, 2004, Volume: 95, Issue:3 Topics: Aged; Antineoplastic Agents, Phytogenic; Cystadenocarcinoma, Serous; Docetaxel; Drug Administration Schedule; Drug Resistance, Neoplasm; Fallopian Tube Neoplasms; Female; Humans; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Peritoneal Neoplasms; Taxoids	2004
SCOTROC 2B: feasibility of carboplatin followed by docetaxel or docetaxel-irinotecan as first-line therapy for ovarian cancer. British journal of cancer, 2006, Jan-16, Volume: 94, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Camptothecin; Carboplatin; Carcinoma; Disease Progression; Docetaxel; Drug Administration Schedule; Fallopian Tube Neoplasms; Female; Humans; Infusions, Intravenous; Irinotecan; Middle Aged; Ovarian Neoplasms; Peritoneal Neoplasms; Survival Analysis; Taxoids; Treatment Outcome	2006
SCOTROC 2A: carboplatin followed by docetaxel or docetaxel-gemcitabine as first-line chemotherapy for ovarian cancer. British journal of cancer, 2006, Jan-16, Volume: 94, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Deoxycytidine; Disease Progression; Docetaxel; Drug Administration Schedule; Dyspnea; Fallopian Tube Neoplasms; Female; Gemcitabine; Humans; Infusions, Intravenous; Middle Aged; Ovarian Neoplasms; Peritoneal Neoplasms; Survival Analysis; Taxoids; Treatment Outcome	2006
Phase II study of docetaxel and irinotecan combination chemotherapy in metastatic gastric carcinoma. British journal of cancer, 2006, May-22, Volume: 94, Issue:10 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Docetaxel; Dose-Response Relationship, Drug; Female; Humans; Irinotecan; Liver Neoplasms; Male; Middle Aged; Ovarian Neoplasms; Peritoneal Neoplasms; Stomach Neoplasms; Survival Rate; Taxoids	2006
Phase II trial of docetaxel and carboplatin in recurrent platinum-sensitive ovarian, peritoneal and tubal cancer. Gynecologic oncology, 2007, Volume: 104, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Docetaxel; Drug Resistance, Neoplasm; Fallopian Tube Neoplasms; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Peritoneal Neoplasms; Taxoids	2007
Weekly docetaxel and carboplatin for recurrent ovarian and peritoneal cancer: a phase II trial. Gynecologic oncology, 2007, Volume: 105, Issue:2 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Docetaxel; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Peritoneal Neoplasms; Quality of Life; Taxoids	2007
Docetaxel and oxaliplatin combination in second-line treatment of patients with advanced gastric cancer. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2007, Volume: 10, Issue:2 Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Dose-Response Relationship, Drug; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Peritoneal Neoplasms; Stomach Neoplasms; Survival Rate; Taxoids	2007
Reduced dose intensity of docetaxel plus capecitabine as second-line palliative chemotherapy in patients with metastatic gastric cancer: a phase II study. Annals of oncology : official journal of the European Society for Medical Oncology, 2007, Volume: 18 Suppl 6 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Palliative Care; Peritoneal Neoplasms; Stomach Neoplasms; Taxoids	2007
A multicentre phase II study of docetaxel plus cisplatin for the treatment of advanced gastric cancer. Chemotherapy, 2007, Volume: 53, Issue:6 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Female; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Peritoneal Neoplasms; Prospective Studies; Stomach Neoplasms; Survival Rate; Taxoids; Treatment Outcome	2007
[Neoadjuvant chemotherapy for gastric cancer with peritoneal dissemination]. Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:12 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Neoadjuvant Therapy; Oxonic Acid; Peritoneal Neoplasms; Stomach Neoplasms; Survival Rate; Taxoids; Tegafur	2007
[A multi-centric phase I/II study of intraperitoneal docetaxel combined with S-1 for patients with peritoneal dissemination of gastric cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:12 Topics: Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Humans; Infusions, Parenteral; Oxonic Acid; Peritoneal Neoplasms; Stomach Neoplasms; Taxoids; Tegafur	2007
A phase Ib trial of docetaxel, carboplatin and erlotinib in ovarian, fallopian tube and primary peritoneal cancers. British journal of cancer, 2008, Jun-03, Volume: 98, Issue:11 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Docetaxel; Erlotinib Hydrochloride; Fallopian Tube Neoplasms; Female; Humans; Maximum Tolerated Dose; Middle Aged; Ovarian Neoplasms; Peritoneal Neoplasms; Quinazolines; Taxoids	2008
Docetaxel for patients with paclitaxel-resistant Müllerian carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:14 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Carcinoma; Docetaxel; Drug Resistance, Neoplasm; Fallopian Tube Neoplasms; Female; Humans; Middle Aged; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Prospective Studies; Statistics, Nonparametric; Survival Analysis; Taxoids	2000
Combination chemotherapy with carboplatin and docetaxel in the treatment of cancers of the ovary and fallopian tube and primary carcinoma of the peritoneum. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Apr-01, Volume: 19, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Docetaxel; Drug Hypersensitivity; Fallopian Tube Neoplasms; Female; Humans; Middle Aged; Neutropenia; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Taxoids	2001

Other Studies

79 other study(ies) available for docetaxel anhydrous and Peritoneal Neoplasms

Article	Year
Pigs in a blanket: an unusual presentation of malignant ascites in prostatic adenocarcinoma. BMJ case reports, 2019, Nov-14, Volume: 12, Issue:11 Topics: Adenocarcinoma; Aged, 80 and over; Antineoplastic Agents; Ascites; Benzamides; Docetaxel; Humans; Male; Nitriles; Peritoneal Neoplasms; Phenylthiohydantoin; Prostatic Neoplasms; Treatment Outcome	2019
Perioperative safety after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei from appendiceal origin: Experience on 254 patients from a single center. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2020, Volume: 46, Issue:4 Pt A Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Appendiceal Neoplasms; Blood Loss, Surgical; Cisplatin; Cytoreduction Surgical Procedures; Docetaxel; Erythrocyte Transfusion; Female; Humans; Hyperthermia, Induced; Intestinal Fistula; Male; Middle Aged; Mitomycin; Peritoneal Neoplasms; Postoperative Complications; Postoperative Hemorrhage; Pseudomyxoma Peritonei; Retrospective Studies; Risk Factors; Young Adult	2020
Reply to: Comments on "Systemic exposure of oxaliplatin and docetaxel in gastric patients with peritonitis carcinomatosis treated with intraperitoneal hyperthermic chemotherapy". European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2020, Volume: 46, Issue:12 Topics: Docetaxel; Humans; Hyperthermic Intraperitoneal Chemotherapy; Oxaliplatin; Peritoneal Neoplasms; Peritonitis; Stomach Neoplasms	2020
Comments on "Systemic exposure of oxaliplatin and docetaxel in gastric patients with peritonitis carcinomatosis treated with intraperitoneal hyperthermic chemotherapy". European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2021, Volume: 47, Issue:5 Topics: Cytoreduction Surgical Procedures; Docetaxel; Humans; Hyperthermic Intraperitoneal Chemotherapy; Oxaliplatin; Peritoneal Neoplasms; Peritonitis	2021
Clinicopathological characteristics of primary peritoneal epithelioid mesothelioma of clear cell type: A case report. Medicine, 2021, Mar-26, Volume: 100, Issue:12 Topics: Aged; Antineoplastic Agents; Cisplatin; Cytoreduction Surgical Procedures; Docetaxel; Embolization, Therapeutic; Exome Sequencing; Humans; Hyperthermic Intraperitoneal Chemotherapy; Immunohistochemistry; Male; Mesothelioma, Malignant; Pemetrexed; Peritoneal Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Von Hippel-Lindau Tumor Suppressor Protein	2021
Expression of both poly r(C) binding protein 1 (PCBP1) and miRNA-3978 is suppressed in peritoneal gastric cancer metastasis. Scientific reports, 2017, 11-14, Volume: 7, Issue:1 Topics: Adult; Aged; Antineoplastic Agents; Biomarkers, Tumor; Cell Line, Tumor; Cysteine Endopeptidases; DNA-Binding Proteins; Docetaxel; Down-Regulation; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Heterogeneous-Nuclear Ribonucleoproteins; Humans; Male; MicroRNAs; Middle Aged; Peritoneal Neoplasms; Peritoneum; RNA-Binding Proteins; Stomach Neoplasms	2017
Primary peritoneal hepatoid adenocarcinoma: a diagnostic and therapeutic conundrum in patients with gastrointestinal bleeding. BMJ case reports, 2018, Sep-18, Volume: 2018 Topics: Adenocarcinoma; Anemia, Iron-Deficiency; Antineoplastic Agents; Carcinoma, Hepatocellular; Docetaxel; Fatty Liver; Gastrointestinal Hemorrhage; Humans; Liver Neoplasms; Male; Middle Aged; Palliative Care; Peritoneal Neoplasms; Sorafenib	2018
Second-line treatment efficacy and toxicity in older vs. non-older patients with advanced gastric cancer: A multicentre real-world study. Journal of geriatric oncology, 2019, Volume: 10, Issue:4 Topics: Adult; Age Factors; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma; Chemotherapy, Adjuvant; Cohort Studies; Disease Progression; Docetaxel; Female; Fluorouracil; Humans; Irinotecan; Italy; Kaplan-Meier Estimate; L-Lactate Dehydrogenase; Liver Neoplasms; Lymph Nodes; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Metastasis; Neoplasm Staging; Paclitaxel; Peritoneal Neoplasms; Platinum Compounds; Progression-Free Survival; Proportional Hazards Models; Receptor, ErbB-2; Retrospective Studies; Stomach Neoplasms; Treatment Failure	2019
Gemcitabine combined with docetaxel precisely regressed a recurrent leiomyosarcoma peritoneal metastasis in a patient-derived orthotopic xenograft (PDOX) model. Biochemical and biophysical research communications, 2019, 02-19, Volume: 509, Issue:4 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Docetaxel; Gemcitabine; Heterografts; Humans; Leiomyosarcoma; Mice; Mice, Nude; Neoplasm Metastasis; Peritoneal Neoplasms; Recurrence; Salvage Therapy; Treatment Outcome; Tumor Burden	2019
[Three Cases of Advanced Gastric Cancer with Peritoneal Dissemination Successfully Treated with S-1 and Docetaxel Combination Chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2018, Volume: 45, Issue:13 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Female; Gastrectomy; Humans; Male; Neoplasm Recurrence, Local; Oxonic Acid; Peritoneal Neoplasms; Stomach Neoplasms; Tegafur	2018
[A Case of Peritoneal Dissemination of Metastatic Gastric Cancer with Successful Docetaxel and S-1 Combination Therapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2018, Volume: 45, Issue:13 Topics: Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Gastrectomy; Humans; Male; Middle Aged; Oxonic Acid; Peritoneal Neoplasms; Stomach Neoplasms; Tegafur	2018
ASO Author Reflections: Induction Systemic Chemotherapy for Peritoneal Metastasis of Gastric Cancer. Annals of surgical oncology, 2019, Volume: 26, Issue:Suppl 3 Topics: Cisplatin; Docetaxel; Humans; Induction Chemotherapy; Peritoneal Neoplasms; Stomach Neoplasms	2019
A patient with scirrhous stomach cancer treated with combination of hyperthermotherapy and 5-aminolevulinic acid (ALA). Anticancer research, 2013, Volume: 33, Issue:7 Topics: Adenocarcinoma, Scirrhous; Adult; Aminolevulinic Acid; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Signet Ring Cell; Cisplatin; Combined Modality Therapy; Dichloroacetic Acid; Docetaxel; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hyperthermia, Induced; Irinotecan; Ovarian Neoplasms; Oxonic Acid; Paclitaxel; Peritoneal Neoplasms; Photosensitizing Agents; Prognosis; Silicates; Stomach Neoplasms; Taxoids; Tegafur; Titanium	2013
Castrate-resistant prostate cancer with peritoneal metastases treated with docetaxel-based chemotherapy. Urologia internationalis, 2014, Volume: 93, Issue:1 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Docetaxel; Humans; Male; Middle Aged; Neoplasm Grading; Peritoneal Neoplasms; Prostate; Prostatic Neoplasms, Castration-Resistant; Registries; Retrospective Studies; Taxoids; Treatment Outcome	2014
Outcome data of patients with peritoneal carcinomatosis from gastric origin treated by a strategy of bidirectional chemotherapy prior to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a single specialized center in Japan. Annals of surgical oncology, 2014, Volume: 21, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Combined Modality Therapy; Docetaxel; Drug Combinations; Female; Follow-Up Studies; Gastrectomy; Humans; Hyperthermia, Induced; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Oxonic Acid; Peritoneal Neoplasms; Prognosis; Prospective Studies; Stomach Neoplasms; Survival Rate; Taxoids; Tegafur	2014
[A case of gastric cancer with intensive peritoneal dissemination treated with long-term chemotherapy and surgery]. Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:12 Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Docetaxel; Drug Combinations; Fatal Outcome; Humans; Lymphatic Metastasis; Male; Middle Aged; Oxonic Acid; Peritoneal Neoplasms; Salvage Therapy; Stomach Neoplasms; Taxoids; Tegafur	2013
[A case of advanced gastric cancer with peritoneal dissemination recurrence after gastrectomy effectively treated with combination chemotherapy of S-1 and docetaxel]. Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:12 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Gastrectomy; Humans; Male; Oxonic Acid; Peritoneal Neoplasms; Recurrence; Stomach Neoplasms; Taxoids; Tegafur	2013
Peritonectomy and hyperthermic chemotherapy in patients with advanced or recurrent ephitelial ovarian cancer: a single center cohort study. Minerva chirurgica, 2014, Volume: 69, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemotherapy, Adjuvant; Cisplatin; Cohort Studies; Combined Modality Therapy; Disease-Free Survival; Docetaxel; Doxorubicin; Female; Humans; Hyperthermia, Induced; Infusions, Parenteral; Kaplan-Meier Estimate; Laparotomy; Length of Stay; Middle Aged; Neoadjuvant Therapy; Omentum; Ovarian Neoplasms; Peritoneal Neoplasms; Peritoneum; Polyethylene Glycols; Postoperative Complications; Recurrence; Taxoids; Treatment Outcome	2014
Docetaxel load biodegradable porous microspheres for the treatment of colorectal peritoneal carcinomatosis. International journal of biological macromolecules, 2014, Volume: 69 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Docetaxel; Drug Carriers; Lactic Acid; Male; Mice; Microspheres; Particle Size; Peritoneal Neoplasms; Poloxamer; Porosity; Taxoids; Xenograft Model Antitumor Assays	2014
ATP-based chemotherapy response assay in primary or recurrent ovarian and peritoneal cancer. Yonsei medical journal, 2014, Volume: 55, Issue:6 Topics: Adenocarcinoma, Clear Cell; Adenosine Triphosphate; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Ovarian Epithelial; Cisplatin; Docetaxel; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Humans; Ifosfamide; Irinotecan; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Predictive Value of Tests; Sensitivity and Specificity; Taxoids	2014
[A case of successful treatment of peritoneal dissemination from gastric cancer with S-1/DOC chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:12 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Gastrectomy; Humans; Lymphatic Metastasis; Male; Oxonic Acid; Peritoneal Neoplasms; Recurrence; Stomach Neoplasms; Taxoids; Tegafur	2014
Pharmacokinetics of docetaxel during hyperthermic intraperitoneal chemotherapy for peritoneal metastasis. Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:12 Topics: Adult; Aged; Antineoplastic Agents; Combined Modality Therapy; Docetaxel; Female; Humans; Hyperthermia, Induced; Male; Middle Aged; Peritoneal Neoplasms; Taxoids; Young Adult	2014
Efficacy and tolerability of weekly docetaxel, cisplatin, and 5-fluorouracil for locally advanced or metastatic gastric cancer patients with ECOG performance scores of 1 and 2. Asian Pacific journal of cancer prevention : APJCP, 2015, Volume: 16, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Docetaxel; Female; Fluorouracil; Follow-Up Studies; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Peritoneal Neoplasms; Prognosis; Retrospective Studies; Stomach Neoplasms; Survival Rate; Taxoids	2015
Preoperative systemic and intraperitoneal chemotherapy consisting of S-1, cisplatin and docetaxel in patients with marginally resectable gastric cancer. Anticancer research, 2015, Volume: 35, Issue:4 Topics: Adult; Aged; Cisplatin; Docetaxel; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Oxonic Acid; Peritoneal Neoplasms; Retrospective Studies; Stomach Neoplasms; Taxoids; Tegafur	2015
Systemic Chemotherapy using FLOT - Regimen Combined with Cytoreductive Surgery plus HIPEC for Treatment of Peritoneal Metastasized Gastric Cancer. . Hepato-gastroenterology, 2014, Volume: 61, Issue:131 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cytoreduction Surgical Procedures; Docetaxel; Drug Administration Schedule; Female; Fluorouracil; Humans; Hypothermia, Induced; Infusions, Parenteral; Kaplan-Meier Estimate; Leucovorin; Male; Middle Aged; Neoadjuvant Therapy; Organoplatinum Compounds; Oxaliplatin; Peritoneal Neoplasms; Retrospective Studies; Stomach Neoplasms; Taxoids; Time Factors; Treatment Outcome	2014
Reduced preoperative serum albumin and absence of peritoneal dissemination may be predictive factors for long-term survival with advanced gastric cancer with positive cytology test. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2015, Volume: 41, Issue:10 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Docetaxel; Drug Combinations; Female; Gastrectomy; Humans; Hypoalbuminemia; Logistic Models; Male; Middle Aged; Multivariate Analysis; Oxonic Acid; Peritoneal Lavage; Peritoneal Neoplasms; Preoperative Period; Prognosis; Proportional Hazards Models; Retrospective Studies; Serum Albumin; Stomach Neoplasms; Taxoids; Tegafur	2015
Enhanced antitumor effects by docetaxel/LL37-loaded thermosensitive hydrogel nanoparticles in peritoneal carcinomatosis of colorectal cancer. International journal of nanomedicine, 2015, Volume: 10 Topics: Animals; Antimicrobial Cationic Peptides; Antineoplastic Agents; Apoptosis; Cathelicidins; Cell Line, Tumor; Colorectal Neoplasms; DNA Fragmentation; Docetaxel; Fluorescent Antibody Technique; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; Injections, Intraperitoneal; Lactic Acid; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Peritoneal Neoplasms; Platelet Endothelial Cell Adhesion Molecule-1; Polyesters; Polymers; Spectroscopy, Fourier Transform Infrared; Taxoids; Temperature; X-Ray Diffraction	2015
[A Case of Advanced Gastric Cancer with Peritoneal Dissemination Effectively Treated with S-1 and Docetaxel Combination Chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2015, Volume: 42, Issue:12 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Docetaxel; Drug Combinations; Gastrectomy; Humans; Male; Oxonic Acid; Peritoneal Neoplasms; Stomach Neoplasms; Taxoids; Tegafur; Treatment Outcome	2015
Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy for the treatment of primary peritoneal serous carcinoma: Results of a Chinese retrospective study. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, 2016, Volume: 32, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Chemotherapy, Cancer, Regional Perfusion; China; Cisplatin; Combined Modality Therapy; Cytoreduction Surgical Procedures; Docetaxel; Female; Humans; Hyperthermia, Induced; Kaplan-Meier Estimate; Middle Aged; Mitomycin; Paclitaxel; Peritoneal Neoplasms; Retrospective Studies; Taxoids	2016
Jackhammer oesophagus in a case of linitis plastica. BMJ case reports, 2016, May-12, Volume: 2016 Topics: Cisplatin; Colonoscopy; Diagnosis, Differential; Docetaxel; Esophagus; Fatal Outcome; Female; Fluorouracil; Humans; Linitis Plastica; Middle Aged; Peritoneal Neoplasms; Stomach Neoplasms; Taxoids; Tomography, X-Ray Computed	2016
Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel to treat synchronous peritoneal carcinomatosis from gastric cancer: Results from a Chinese center. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2016, Volume: 42, Issue:7 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemotherapy, Cancer, Regional Perfusion; China; Cyclobutanes; Cytoreduction Surgical Procedures; Databases, Factual; Docetaxel; Female; Follow-Up Studies; Humans; Hyperthermia, Induced; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Multiple Primary; Organoplatinum Compounds; Peritoneal Neoplasms; Prognosis; Retrospective Studies; Sample Size; Stomach Neoplasms; Taxoids; Treatment Outcome	2016
Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center. Gynecologic oncology, 2016, Volume: 142, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Cohort Studies; Docetaxel; Fallopian Tube Neoplasms; Female; Guideline Adherence; Humans; Infusions, Intravenous; Infusions, Parenteral; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Retrospective Studies; Taxoids	2016
Does the Number of Neoadjuvant Chemotherapy Cycles before Interval Debulking Surgery Influence Survival in Advanced Ovarian Cancer? Oncology, 2016, Volume: 91, Issue:6 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Chemotherapy, Adjuvant; Cytoreduction Surgical Procedures; Disease-Free Survival; Docetaxel; Fallopian Tube Neoplasms; Female; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Ovarian Neoplasms; Peritoneal Neoplasms; Retrospective Studies; Survival Rate; Taxoids	2016
The Impact of the Duration of Adjuvant Chemotherapy on Survival in Patients with Epithelial Ovarian Cancer - A Retrospective Study. PloS one, 2017, Volume: 12, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ovarian Epithelial; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Docetaxel; Female; Humans; Multivariate Analysis; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Peritoneal Neoplasms; Prognosis; Proportional Hazards Models; Retrospective Studies; Taxoids	2017
Surfactants influence the distribution of taxanes in peritoneal dissemination tumor-bearing rats. Cancer letters, 2010, Jan-28, Volume: 287, Issue:2 Topics: Animals; Antineoplastic Agents, Phytogenic; Area Under Curve; Ascites; Biological Transport; Carcinoma, Hepatocellular; Cell Line, Tumor; Docetaxel; Female; Glycerol; Injections, Intraperitoneal; Liver Neoplasms; Paclitaxel; Peritoneal Neoplasms; Polysorbates; Rats; Surface-Active Agents; Taxoids; Tissue Distribution	2010
Safety and efficacy of bidirectional chemotherapy for treatment of patients with peritoneal dissemination from gastric cancer: Selection for cytoreductive surgery. Journal of surgical oncology, 2009, Sep-15, Volume: 100, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Combined Modality Therapy; Docetaxel; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Selection; Peritoneal Neoplasms; Prognosis; Stomach Neoplasms; Survival Rate; Taxoids	2009
[A case of gastric cancer with peritoneal dissemination-efficacy of combination therapy with S-1 and docetaxel]. Gan to kagaku ryoho. Cancer & chemotherapy, 2009, Volume: 36, Issue:9 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Female; Humans; Middle Aged; Oxonic Acid; Peritoneal Neoplasms; Stomach Neoplasms; Taxoids; Tegafur	2009
Successful treatment of metastatic pancreatic adenocarcinoma with combination chemotherapy regimens. International journal of clinical oncology, 2009, Volume: 14, Issue:5 Topics: Adenocarcinoma, Mucinous; Adult; Albumins; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Biopsy, Fine-Needle; Capecitabine; Cisplatin; Deoxycytidine; Docetaxel; Female; Fluorouracil; Gemcitabine; Humans; Liver Neoplasms; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Pancreatic Neoplasms; Peritoneal Neoplasms; Taxoids; Tomography, X-Ray Computed; Treatment Outcome	2009
[Two cases of advanced gastric cancer with peritoneal dissemination, and Virchow's metastases successfully treated by combination therapy of S-1 and docetaxel]. Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:1 Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Ascites; Docetaxel; Drug Combinations; Female; Gastrectomy; Humans; Lymphatic Metastasis; Male; Middle Aged; Oxonic Acid; Peritoneal Neoplasms; Peritonitis; Stomach Neoplasms; Taxoids; Tegafur	2010
The efficacy of the frontline platinum-based combination chemotherapy in malignant peritoneal mesothelioma. Japanese journal of clinical oncology, 2010, Volume: 40, Issue:11 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Deoxycytidine; Docetaxel; Doxorubicin; Female; Gemcitabine; Glutamates; Guanine; Humans; Male; Mesothelioma; Middle Aged; Pemetrexed; Peritoneal Neoplasms; Pleural Neoplasms; Survival Rate; Taxoids; Treatment Outcome	2010
[A very elderly case of recurrent gastric cancer with peritoneal dissemination effectively treated by combination chemotherapy of docetaxel (DOC) and S-1]. Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:8 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Docetaxel; Drug Combinations; Gastrectomy; Humans; Liver Neoplasms; Male; Oxonic Acid; Peritoneal Neoplasms; Remission Induction; Stomach Neoplasms; Taxoids; Tegafur; Tomography, X-Ray Computed	2010
Multidrug resistance gene (MDR-1) and risk of brain metastasis in epithelial ovarian, fallopian tube, and peritoneal cancer. American journal of clinical oncology, 2011, Volume: 34, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biomarkers, Tumor; Brachytherapy; Brain Neoplasms; Carboplatin; Carcinoma, Ovarian Epithelial; Cisplatin; Cohort Studies; Combined Modality Therapy; Docetaxel; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fallopian Tube Neoplasms; Female; Follow-Up Studies; Humans; Immunoenzyme Techniques; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Retrospective Studies; Risk Factors; Survival Rate; Taxoids; Treatment Outcome	2011
Esophageal adenocarcinoma presenting as pseudo-achalasia in a patient with juvenile polyposis syndrome: an enemy out of the blue. Digestive diseases and sciences, 2011, Volume: 56, Issue:7 Topics: Adenocarcinoma; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiemetics; Antineoplastic Agents; Antineoplastic Protocols; Cisplatin; Combined Modality Therapy; Docetaxel; Epirubicin; Esophageal Achalasia; Esophageal Neoplasms; Fatal Outcome; Fluorouracil; Humans; Intestinal Polyposis; Liver Neoplasms; Male; Neoplastic Syndromes, Hereditary; Peritoneal Neoplasms; Proton Pump Inhibitors; Taxoids; Trastuzumab	2011
Second-line chemotherapy with docetaxel and carboplatin in paclitaxel and platinum-pretreated ovarian, fallopian tube, and peritoneal cancer. Medical oncology (Northwood, London, England), 2012, Volume: 29, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Docetaxel; Drug Resistance, Neoplasm; Fallopian Tube Neoplasms; Female; Follow-Up Studies; Humans; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Platinum; Retrospective Studies; Salvage Therapy; Taxoids; Treatment Outcome	2012
Pharmacologic and phenotypic study of docetaxel in patients with ovarian or primary peritoneal cancer. Cancer chemotherapy and pharmacology, 2011, Volume: 68, Issue:5 Topics: Adult; Aged; Antineoplastic Agents; Base Sequence; Chromatography, Liquid; DNA Primers; Docetaxel; Female; Humans; Male; Middle Aged; Ovarian Neoplasms; Peritoneal Neoplasms; Pharmacogenetics; Polymerase Chain Reaction; Tandem Mass Spectrometry; Taxoids	2011
Neoadjuvant intraperitoneal and systemic chemotherapy for gastric cancer patients with peritoneal dissemination. Annals of surgical oncology, 2011, Volume: 18, Issue:13 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Docetaxel; Feasibility Studies; Female; Fluorouracil; Follow-Up Studies; Gastrectomy; Humans; Lymph Node Excision; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Peritoneal Neoplasms; Postoperative Complications; Prognosis; Prospective Studies; Stomach Neoplasms; Survival Rate; Taxoids	2011
WT1 peptide vaccine stabilized intractable ovarian cancer patient for one year: a case report. Anticancer research, 2011, Volume: 31, Issue:7 Topics: Adjuvants, Immunologic; Biomarkers, Tumor; CA-125 Antigen; Cancer Vaccines; Carboplatin; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Cystadenocarcinoma, Serous; Docetaxel; Female; HLA-A Antigens; HLA-A24 Antigen; Humans; Immunotherapy, Active; Membrane Proteins; Middle Aged; Omentum; Ovarian Neoplasms; Paclitaxel; Peptide Fragments; Peritoneal Neoplasms; Taxoids; Tumor Burden; Vaccines, Subunit; WT1 Proteins	2011
Intraperitoneal docetaxel combined with S-1 for advanced gastric cancer with peritoneal dissemination. Journal of surgical oncology, 2012, Volume: 105, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Docetaxel; Drug Combinations; Female; Follow-Up Studies; Humans; Injections, Intraperitoneal; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Oxonic Acid; Peritoneal Neoplasms; Postoperative Complications; Prospective Studies; Stomach Neoplasms; Survival Rate; Taxoids; Tegafur; Treatment Outcome	2012
Second-line chemotherapy for carboplatin/paclitaxel-refractory ovarian cancer: are multi-agent chemotherapies of little value truly? European journal of gynaecological oncology, 2011, Volume: 32, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Cisplatin; Docetaxel; Drug Resistance, Neoplasm; Fallopian Tube Neoplasms; Female; Humans; Irinotecan; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Taxoids	2011
[Peritoneal lavage cytology under local anesthesia for detection of peritoneal recurrence after surgery]. Gan to kagaku ryoho. Cancer & chemotherapy, 2011, Volume: 38, Issue:12 Topics: Aged; Anesthesia, Local; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Humans; Male; Middle Aged; Neoadjuvant Therapy; Oxonic Acid; Peritoneal Lavage; Peritoneal Neoplasms; Recurrence; Stomach Neoplasms; Taxoids; Tegafur; Tomography, X-Ray Computed	2011
[A case of advanced gastric cancer with peritoneal dissemination successfully treated with S-1 and intraperitoneal docetaxel administration]. Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Combined Modality Therapy; Docetaxel; Drug Combinations; Humans; Male; Oxonic Acid; Peritoneal Neoplasms; Remission Induction; Stomach Neoplasms; Taxoids; Tegafur; Tomography, X-Ray Computed	2012
[A case report of advanced gastric cancer with peritoneal dissemination effectively treated by combination chemotherapy of S-1 and docetaxel]. Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39, Issue:6 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Humans; Male; Neoplasm Staging; Oxonic Acid; Peritoneal Neoplasms; Stomach Neoplasms; Taxoids; Tegafur; Tomography, X-Ray Computed	2012
[A case of gastric cancer with peritoneal dissemination who achieved long survival from control of ascites for over 2 years by successive treatments with S-1 in combination with docetaxel as first-line followed by irinotecan in combination with cisplatin Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39, Issue:7 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Ascites; Camptothecin; Cisplatin; Docetaxel; Drug Combinations; Fatal Outcome; Humans; Irinotecan; Male; Oxonic Acid; Peritoneal Neoplasms; Salvage Therapy; Stomach Neoplasms; Taxoids; Tegafur	2012
[A case of gastric cancer with peritoneal dissemination and massive ascites successfully treated with S-1/docetaxel therapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Ascites; Biopsy; Docetaxel; Drug Combinations; Female; Humans; Middle Aged; Oxonic Acid; Peritoneal Neoplasms; Stomach Neoplasms; Taxoids; Tegafur; Tomography, X-Ray Computed	2012
Prognostic factors in first-line chemotherapy treated metastatic gastric cancer patients: a retrospective study. Asian Pacific journal of cancer prevention : APJCP, 2012, Volume: 13, Issue:8 Topics: Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Signet Ring Cell; Cisplatin; Docetaxel; Female; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Grading; Neoplasm Staging; Peritoneal Neoplasms; Prognosis; Retrospective Studies; Stomach Neoplasms; Taxoids; Young Adult	2012
Docetaxel-loaded thermoresponsive conjugated linoleic acid-incorporated poloxamer hydrogel for the suppression of peritoneal metastasis of gastric cancer. Biomaterials, 2013, Volume: 34, Issue:4 Topics: Animals; Antineoplastic Agents; Delayed-Action Preparations; Docetaxel; Hot Temperature; Hydrogels; Linoleic Acid; Male; Mice; Mice, Inbred BALB C; Nanocapsules; Peritoneal Neoplasms; Poloxamer; Stomach Neoplasms; Taxoids; Treatment Outcome	2013
Pharmacokinetics of docetaxel in gastric cancer patients with malignant ascites. Cancer chemotherapy and pharmacology, 2013, Volume: 71, Issue:3 Topics: Aged; Antineoplastic Agents, Phytogenic; Ascites; Docetaxel; Female; Gastrectomy; Humans; Injections, Intravenous; Male; Middle Aged; Peritoneal Neoplasms; Prospective Studies; Stomach Neoplasms; Taxoids	2013
[Pharmacologic study of intraperitoneal docetaxel in gastric cancer patients with peritoneal dissemination]. Gan to kagaku ryoho. Cancer & chemotherapy, 2002, Volume: 29, Issue:10 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Female; Humans; Infusions, Parenteral; Male; Middle Aged; Mitomycin; Paclitaxel; Peritoneal Neoplasms; Stomach Neoplasms; Taxoids; Vindesine	2002
Pharmacokinetic study of docetaxel in intraoperative hyperthermic i.p. chemotherapy for ovarian cancer. Anti-cancer drugs, 2003, Volume: 14, Issue:2 Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Area Under Curve; Biological Availability; Carcinoma; Combined Modality Therapy; Docetaxel; Female; Humans; Hyperthermia, Induced; Injections, Intraperitoneal; Intraoperative Care; Middle Aged; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Taxoids; Tissue Distribution	2003
Cyclosporin-A enhances docetaxel-induced apoptosis through inhibition of nuclear factor-kappaB activation in human gastric carcinoma cells. Clinical cancer research : an official journal of the American Association for Cancer Research, 2003, Nov-01, Volume: 9, Issue:14 Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Caspase Inhibitors; Caspases; Chromatography, High Pressure Liquid; Colonic Neoplasms; Cyclosporine; Docetaxel; Drug Combinations; Enzyme Inhibitors; Female; Humans; Mice; Mice, Inbred BALB C; NF-kappa B; Peritoneal Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Stomach Neoplasms; Taxoids; Tumor Cells, Cultured	2003
Phase 2 trial of single agent docetaxel in platinum and paclitaxel-refractory ovarian cancer, fallopian tube cancer, and primary carcinoma of the peritoneum. Gynecologic oncology, 2003, Volume: 91, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Carboplatin; Cisplatin; Docetaxel; Drug Resistance, Neoplasm; Fallopian Tube Neoplasms; Female; Humans; Middle Aged; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Taxoids	2003
Effect of intraperitoneal administration of docetaxel on peritoneal dissemination of gastric cancer. Cancer letters, 2004, Jul-16, Volume: 210, Issue:2 Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoembryonic Antigen; Docetaxel; Female; Infusions, Parenteral; Mice; Mice, Nude; Neoplasms, Experimental; Peritoneal Neoplasms; Stomach Neoplasms; Survival Analysis; Taxoids	2004
Survival following the documentation of platinum and taxane resistance in ovarian cancer: a single institution experience involving multiple phase 2 clinical trials. Gynecologic oncology, 2004, Volume: 93, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Bridged-Ring Compounds; Clinical Trials, Phase II as Topic; Deoxycytidine; Docetaxel; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fallopian Tube Neoplasms; Female; Gemcitabine; Humans; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Peritoneal Neoplasms; Retrospective Studies; Survival Rate; Taxoids; Topotecan	2004
[A case of scirrhous carcinoma of the stomach with malignant pleural and peritoneal carcinomatosis responding to the local administration of docetaxel (TXT)]. Gan to kagaku ryoho. Cancer & chemotherapy, 2004, Volume: 31, Issue:11 Topics: Adenocarcinoma, Scirrhous; Adult; Antineoplastic Agents, Phytogenic; Ascites; Docetaxel; Female; Gastrectomy; Humans; Infusions, Intravenous; Infusions, Parenteral; Peritoneal Neoplasms; Peritonitis; Pleural Effusion; Pleural Neoplasms; Quality of Life; Stomach Neoplasms; Taxoids; Thoracic Cavity	2004
Pharmacokinetic advantage of intraperitoneal injection of docetaxel in the treatment for peritoneal dissemination of cancer in mice. The Journal of pharmacy and pharmacology, 2005, Volume: 57, Issue:2 Topics: Animals; Area Under Curve; Ascitic Fluid; Cell Line, Tumor; Docetaxel; Female; Humans; Injections, Intraperitoneal; Injections, Intravenous; Intestinal Mucosa; Intestines; Japan; Liver; Mice; Mice, Inbred ICR; Neoplasm Transplantation; Neoplasms, Experimental; Peritoneal Cavity; Peritoneal Neoplasms; Spleen; Taxoids; Time Factors	2005
[A case of a nonresected gastric cancer with peritoneal dissemination maintained on TS-1 and docetaxel combination chemotherapy with good QOL]. Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:2 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Administration Schedule; Drug Combinations; Humans; Male; Oxonic Acid; Peritoneal Neoplasms; Pyridines; Quality of Life; Stomach Neoplasms; Taxoids; Tegafur	2005
A pilot study of weekly docetaxel therapy for recurrent ovarian cancer, tubal cancer, and primary peritoneal cancer. European journal of gynaecological oncology, 2005, Volume: 26, Issue:3 Topics: Adult; Aged; Antineoplastic Agents; Biomarkers, Tumor; CA-125 Antigen; Docetaxel; Drug Administration Schedule; Fallopian Tube Neoplasms; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Pilot Projects; Platinum Compounds; Taxoids; Treatment Outcome	2005
[A case of remnant gastric cancer with multiple bone metastasis and peritoneal dissemination; efficacy of combination therapy of docetaxel and TS-1]. Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:7 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Docetaxel; Drug Administration Schedule; Drug Combinations; Female; Gastrectomy; Humans; Oxonic Acid; Peritoneal Neoplasms; Pyridines; Stomach Neoplasms; Taxoids; Tegafur	2005
[A case of gastric cancer with peritoneal recurrence which developed during adjuvant administration of TS-1 showing complete response by weekly docetaxel regimen]. Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:7 Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Carcinoembryonic Antigen; Chemotherapy, Adjuvant; Docetaxel; Drug Administration Schedule; Drug Combinations; Gastrectomy; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Oxonic Acid; Peritoneal Neoplasms; Pyridines; Stomach Neoplasms; Taxoids; Tegafur	2005
[Effect of intraperitoneal chemotherapy on experimental peritoneal dissemination of gastric cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:11 Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carboplatin; Cisplatin; Docetaxel; Drug Combinations; Drug Screening Assays, Antitumor; Fluorouracil; Infusions, Parenteral; Mice; Mice, Nude; Neoplasm Seeding; Oxonic Acid; Peritoneal Neoplasms; Pyridines; Stomach Neoplasms; Taxoids; Tegafur	2005
[A case of nonresected gastric cancer with peritoneal dissemination maintained on TS-1, cisplatin (CDDP) and docetaxel combination chemotherapy with good QOL]. Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:2 Topics: Adenocarcinoma, Mucinous; Antineoplastic Combined Chemotherapy Protocols; Cardia; Cisplatin; Docetaxel; Drug Administration Schedule; Drug Combinations; Female; Humans; Middle Aged; Oxonic Acid; Peritoneal Neoplasms; Pyridines; Quality of Life; Stomach Neoplasms; Taxoids; Tegafur	2006
Neoadjuvant treatment of gastric cancer with peritoneal dissemination. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2006, Volume: 32, Issue:6 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Docetaxel; Female; Fluorouracil; Humans; Infusions, Parenteral; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Peritoneal Neoplasms; Quality of Life; Stomach Neoplasms; Survival Rate; Taxoids; Treatment Outcome	2006
[A case of duodenal carcinoma with massive peritoneal carcinomatosis complicating a pulmonary embolism]. Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:11 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Drug Therapy, Combination; Duodenal Neoplasms; Female; Heparin; Humans; Middle Aged; Oxonic Acid; Peritoneal Neoplasms; Pulmonary Embolism; Quality of Life; Taxoids; Tegafur; Warfarin	2006
[A case report of advanced gastric cancer with carcinomatous ascites successfully treated by outpatient chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:1 Topics: Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Ascites; Ascitic Fluid; Cisplatin; Docetaxel; Drug Administration Schedule; Drug Combinations; Fluorouracil; Humans; Male; Middle Aged; Oxonic Acid; Paclitaxel; Peritoneal Neoplasms; Quality of Life; Stomach Neoplasms; Taxoids; Tegafur	2007
[Long survival and effective treatment of unresectable gastric cancer by TS-1 based chemotherapy with a sequential combination]. Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:2 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Administration Schedule; Female; Humans; Middle Aged; Peritoneal Neoplasms; Quality of Life; Silicates; Stomach Neoplasms; Survivors; Taxoids; Titanium	2007
[Complete regression after neoadjuvant chemotherapy in locally advanced gastric cancer causing peritonitis carcinomatosa--a case report]. Magyar sebeszet, 2006, Volume: 59, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Ascites; Carcinoma; Chemotherapy, Adjuvant; Cisplatin; Docetaxel; Fluorouracil; Gastrectomy; Humans; Male; Middle Aged; Neoadjuvant Therapy; Peritoneal Neoplasms; Peritonitis; Stomach Neoplasms; Taxoids; Treatment Outcome	2006
Dual anti-cancer effects of weekly intraperitoneal docetaxel in treatment of advanced gastric cancer patients with peritoneal carcinomatosis: a feasibility and pharmacokinetic study. Oncology reports, 2008, Volume: 19, Issue:5 Topics: Antineoplastic Agents; Area Under Curve; Capillaries; Docetaxel; Feasibility Studies; Female; Humans; Kinetics; Lymphatic Metastasis; Male; Peritoneal Neoplasms; Recurrence; Stomach Neoplasms; Taxoids; Time Factors; Treatment Outcome	2008
Comparison of paclitaxel and docetaxel activity on human ovarian carcinoma xenografts. European journal of cancer (Oxford, England : 1990), 1994, Volume: 30A, Issue:5 Topics: Animals; Antineoplastic Agents, Phytogenic; Ascites; Docetaxel; Dose-Response Relationship, Drug; Female; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Taxoids; Transplantation, Heterologous	1994
CA 125: a misleading tumor marker? International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 1996, Volume: 55, Issue:2 Topics: Antineoplastic Agents, Phytogenic; CA-125 Antigen; Cystadenocarcinoma, Mucinous; Docetaxel; Female; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Taxoids	1996